... Frieman pointed out. This research, done in collaboration with Regeneron, a biopharmaceutical company based in Tarrytown, New York, used several of the company's proprietary technologies to search for and validate effective antibodies targeting the ...
http://ift.tt/1T02skw
No comments:
Post a Comment